$IGXT
IntelGenx Technologies Corp. Stock $igxt

$igxt Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000106299324010322 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue		$174.0K
YoY Change		7.41%
Cost Of Revenue		$484.0K
YoY Change		2.54%
Gross Profit		-$310.0K
YoY Change		0.0%
Gross Profit Margin		-178.16%
Selling, General & Admin		$1.934M
YoY Change		49.34%
% of Gross Profit
Research & Development		$789.0K
YoY Change		-4.01%
% of Gross Profit
Depreciation & Amortization		$202.0K
YoY Change		5.21%
% of Gross Profit
Operating Expenses		$3.409M
YoY Change		22.58%
Operating Profit		-$3.235M
YoY Change		23.52%
Interest Expense		$792.0K
YoY Change		148.28%
% of Operating Profit
Other Income/Expense, Net		-$792.0K
YoY Change		159.67%
Pretax Income		-$4.027M
YoY Change		37.72%
Income Tax
% Of Pretax Income
Net Earnings		-$4.027M
YoY Change		37.72%
Net Earnings / Revenue		-2314.37%
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share		-$0.02
COMMON SHARES
Basic Shares Outstanding	174.7M shares	174.7M shares
Diluted Shares Outstanding		174.7M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$772.0K
YoY Change		-79.9%
Cash & Equivalents		$772.0K
Short-Term Investments
Other Short-Term Assets		$313.0K
YoY Change		-22.91%
Inventory		$173.0K
Prepaid Expenses		$239.0K
Receivables		$618.0K
Other Receivables		$201.0K
Total Short-Term Assets		$2.077M
YoY Change		-59.29%
LONG-TERM ASSETS
Property, Plant & Equipment		$3.682M
YoY Change		-14.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$244.0K
YoY Change		-0.41%
Total Long-Term Assets		$4.471M
YoY Change		-14.66%
TOTAL ASSETS
Total Short-Term Assets		$2.077M
Total Long-Term Assets		$4.471M
Total Assets		$6.548M
YoY Change		-36.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$3.023M
YoY Change		20.25%
Accrued Expenses		$1.668M
YoY Change		600.84%
Deferred Revenue
YoY Change
Short-Term Debt		$10.73M
YoY Change
Long-Term Debt Due		$82.00K
YoY Change		-99.04%
Total Short-Term Liabilities		$16.52M
YoY Change		46.3%
LONG-TERM LIABILITIES
Long-Term Debt		$5.228M
YoY Change
Other Long-Term Liabilities		$170.0K
YoY Change		-54.67%
Total Long-Term Liabilities		$5.398M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$16.52M
Total Long-Term Liabilities		$5.398M
Total Liabilities		$21.91M
YoY Change		31.58%
SHAREHOLDERS EQUITY
Retained Earnings		-$82.48M
YoY Change		15.44%
Common Stock		$1.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$15.37M
YoY Change
Total Liabilities & Shareholders Equity		$6.548M
YoY Change		-36.68%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income		-$4.027M
YoY Change		37.72%
Depreciation, Depletion And Amortization		$202.0K
YoY Change		5.21%
Cash From Operating Activities		-$2.856M
YoY Change		26.26%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$943.0K
YoY Change		-74.15%
NET CHANGE
Cash From Operating Activities		-$2.856M
Cash From Investing Activities		$0.00
Cash From Financing Activities		$943.0K
Net Change In Cash		-$1.913M
YoY Change		-245.81%
FREE CASH FLOW
Cash From Operating Activities		-$2.856M
Capital Expenditures		$0.00
Free Cash Flow		-$2.856M
YoY Change		22.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	162000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	789000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	230000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	82000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78457000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2145000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2453000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-15366000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2924000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	267000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	772000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-46000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	174658096	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	174658096	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2024Q1	igxt	Sales Tax Assessments Interest And Penalties SalesTaxAssessmentsInterestAndPenalties	34000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Cash Cash	772000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	622000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	239000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3958000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	250000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	545000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	633000	usd
CY2024Q1	us-gaap	Assets Assets	6548000	usd
CY2023Q4	us-gaap	Assets Assets	8282000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	242000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	16516000	usd
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	670000	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	7401000	usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4538000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4438000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	170000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	37000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69262000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68662000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-82484000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8282000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-15366000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-792000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	822000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1934000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	202000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3409000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2781000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3235000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2619000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2924000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	308000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2920000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174646196	shares
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	33000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2856000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2262000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	173000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	71000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6018000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	580000000	shares
CY2024Q1	igxt	Transaction Price Allocated To Remaining Per Formance Obligation TransactionPriceAllocatedToRemainingPerFormanceObligation	3347000	usd
CY2024Q1	igxt	Research And Development Milestone Payments ResearchAndDevelopmentMilestonePayments	2411000	usd
CY2024Q1	igxt	Percentages Of Recognized In Next Three Year PercentagesOfRecognizedInNextThreeYear	1	pure
CY2024Q1	igxt	Commercial Sales Milestone Payments CommercialSalesMilestonePayments	395000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	65000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	67000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	511000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	99000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	412000	usd
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0375	pure
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2000	usd
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6420 Abrams
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Ville Saint Laurent
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	QC
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	H4S 1Y2
CY2024Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2024Q1	dei	City Area Code CityAreaCode	514
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	331-7440
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	174658096	shares
CY2023Q4	us-gaap	Cash Cash	2282000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	618000	usd
CY2024Q1	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	201000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	244000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3023000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	21914000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	20529000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	174658096	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	174658096	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	174658096	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12247000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	300000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4027000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	174000	usd
CY2024Q1	us-gaap	Revenues Revenues	174000	usd
CY2023Q1	us-gaap	Revenues Revenues	162000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	792000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3719000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	174658096	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4027000	usd
CY2024Q1	igxt	Total Adjustments TotalAdjustments	-2902000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	75000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	37000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-266000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	22000	usd
CY2024Q1	igxt	Proceeds From Issuance Convertible Notes ProceedsFromIssuanceConvertibleNotes	0	usd
CY2023Q1	igxt	Proceeds From Issuance Convertible Notes ProceedsFromIssuanceConvertibleNotes	697000	usd
CY2024Q1	igxt	Payments For Transaction Costs Of Convertible Notes PaymentsForTransactionCostsOfConvertibleNotes	0	usd
CY2023Q1	igxt	Payments For Transaction Costs Of Convertible Notes PaymentsForTransactionCostsOfConvertibleNotes	40000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3648000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-74000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1312000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9700000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	200000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	267000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	44000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	36000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	102000	usd
CY2024Q1	igxt	Sales Tax Assessments Amount SalesTaxAssessmentsAmount	314000	usd
CY2024Q1	igxt	Amount Of Sales Taxes Expenses Increase AmountOfSalesTaxesExpensesIncrease	280000	usd
CY2024Q1	igxt	Amount Of Net Earnings Decrease AmountOfNetEarningsDecrease	280000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2077000	usd
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Entity File Number EntityFileNumber	000-31187
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0638336
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	168000	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	75000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	173000	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001098880
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-12247000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6548000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	308000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-305000	usd
CY2024Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
CY2023Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	1000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	308000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	202000	usd
CY2023Q1	igxt	Total Adjustments TotalAdjustments	-2528000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	580000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	68000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	223000	usd
CY2024Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	74000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3441000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3682000	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1009000	usd
CY2024Q1	igxt	Adjustments To Additional Paid In Capital Warrant Issued Two AdjustmentsToAdditionalPaidInCapitalWarrantIssuedTwo	300000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	484000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	472000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	174646196	shares
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	943000	usd
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	103000	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	11000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	104000	usd
CY2018Q2	igxt	Warrants Issued During Period Warrants WarrantsIssuedDuringPeriodWarrants	7690	shares
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	INTELGENX TECHNOLOGIES CORP.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	us-gaap	Inventory Net InventoryNet	71000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2661000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1426000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1249000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	248000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	90000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1118000	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2585000	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	2557000	usd
CY2024Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	500000	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	500000	usd
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	7649000	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8423000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	580000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	580000000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	174658096	shares
CY2024Q1	igxt	Warrants Transaction Cost WarrantsTransactionCost	11000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1295000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	192000	usd
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	14000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	319000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4027000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	174658096	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Depreciation Depreciation	192000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11000	usd
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	381000	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	48000	usd
CY2024Q1	igxt	Dsu Expenses DsuExpenses	244000	usd
CY2023Q1	igxt	Dsu Expenses DsuExpenses	144000	usd
CY2024Q1	igxt	Lease Expense LeaseExpense	-2000	usd
CY2023Q1	igxt	Lease Expense LeaseExpense	1000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-119000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	16000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	125000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	177000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-109000	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3000000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	35000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1913000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	403000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2282000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1210000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2520000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	772000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3682000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3958000	usd
CY2018Q2	igxt	Units Issued During Period UnitsIssuedDuringPeriod	320	shares
CY2018Q2	igxt	Subscription Price Of Units SubscriptionPriceOfUnits	10000	usd
CY2018Q2	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	3200000	usd
CY2018Q2	igxt	Common Shares Per Unit Issued CommonSharesPerUnitIssued	7940	shares
CY2018Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5000	usd
CY2018Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2018Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2018Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.8
CY2018Q2	igxt	Warrants Issued During Period Exercise Price WarrantsIssuedDuringPeriodExercisePrice	0.8
CY2018Q2	igxt	Commission Paid To Agents CommissionPaidToAgents	157800	usd
CY2018Q2	igxt	Agent Warrants Issued During Period AgentWarrantsIssuedDuringPeriod	243275	shares
CY2018Q2	igxt	Warrants Issued During Period Exercise Price WarrantsIssuedDuringPeriodExercisePrice	0.8
CY2018Q2	igxt	Warrants Issued During Period Value WarrantsIssuedDuringPeriodValue	50000	usd
CY2024Q1	igxt	Gross Proceeds Of Units GrossProceedsOfUnits	3200000	usd
CY2024Q1	igxt	Transaction Costs Of Units TransactionCostsOfUnits	328000	usd
CY2024Q1	igxt	Net Proceeds Of Units NetProceedsOfUnits	2872000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1000000	usd
CY2024Q1	igxt	Transaction Costs Of Debt TransactionCostsOfDebt	35000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	965000	usd
CY2023Q4	igxt	Number Of Authorized Shares Of Capital Stock NumberOfAuthorizedSharesOfCapitalStock	470000000	shares
CY2024Q1	igxt	Number Of Authorized Shares Of Capital Stock NumberOfAuthorizedSharesOfCapitalStock	600000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	580000000	shares
CY2024Q1	us-gaap	Revenues Revenues	174000	usd
CY2023Q1	us-gaap	Revenues Revenues	162000	usd
CY2024Q1	us-gaap	Revenues Revenues	174000	usd
CY2023Q1	us-gaap	Revenues Revenues	162000	usd
CY2024Q1	us-gaap	Revenues Revenues	174000	usd
CY2023Q1	us-gaap	Revenues Revenues	162000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	242000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	170000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	22000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	82000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20000	usd

Files In Submission

Name	View Source	Status
0001062993-24-010322-index-headers.html	Edgar Link	pending
0001062993-24-010322-index.html	Edgar Link	pending
0001062993-24-010322.txt	Edgar Link	pending
0001062993-24-010322-xbrl.zip	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10q.htm	Edgar Link	pending
igxt-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
igxt-20240331_def.xml	Edgar Link	unprocessable
igxt-20240331_lab.xml	Edgar Link	unprocessable
igxt-20240331_pre.xml	Edgar Link	unprocessable
form10q_htm.xml	Edgar Link	completed
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
igxt-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IGXT
IntelGenx Technologies Corp. Stock $igxt

2024 Q2 Form 10-Q Financial Statement

#000106299324010322 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IGXT IntelGenx Technologies Corp. Stock $igxt

2024 Q2 Form 10-Q Financial Statement

#000106299324010322 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IGXT
IntelGenx Technologies Corp. Stock $igxt